Data Element Repository
General eCQM Information
| CMS Measure ID | CMS129v9 |
|---|---|
| NQF Number | 0389e |
| Measure Description |
Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer |
| Initial Population | All patients, regardless of age, with a diagnosis of prostate cancer |
| Denominator Statement |
Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy |
| Denominator Exclusions |
None |
| Numerator Statement |
Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer |
| Numerator Exclusions |
Not Applicable |
| Denominator Exceptions |
Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, bone scan ordered by someone other than reporting physician) |
| Measure Steward | PCPI(R) Foundation (PCPI[R]) |
| Domain | Efficiency and Cost Reduction |
| Measure Scoring | Proportion measure |
| Measure Type | Process measure |
| Improvement Notation |
Higher score indicates better quality |
| Guidance |
A higher score indicates appropriate treatment of patients with prostate cancer at low (or very low) risk of recurrence. Only patients with prostate cancer with low (or very low) risk of recurrence will be counted in the performance denominator of this measure. |
| Quality ID | 102 |
| Meaningful Measure | Appropriate Use of Healthcare |
| Telehealth Eligible | No |
| Next Version | |
| Previous Version |
Header
-
Updated eCQM version number.
Measure Section: eCQM Version number
Source of Change: Measure Lead
-
Added 'e' to NQF number.
Measure Section: NQF Number
Source of Change: Standards Update
-
Updated description statement with removal of references to cryotherapy to align with the updated guideline.
Measure Section: Description
Source of Change: Expert Work Group Review
-
Updated copyright.
Measure Section: Copyright
Source of Change: Annual Update
-
Updated disclaimer.
Measure Section: Disclaimer
Source of Change: Measure Lead
-
Updated rationale statement with in-text citation date to reflect updated reference.
Measure Section: Rationale
Source of Change: Measure Lead
-
Updated clinical recommendation statement to align with current guidelines.
Measure Section: Clinical Recommendation Statement
Source of Change: Measure Lead
-
Updated references to align with American Psychological Association (APA) style.
Measure Section: Reference
Source of Change: Measure Lead
-
Updated references.
Measure Section: Reference
Source of Change: Measure Lead
-
Updated definition statement to align with current guideline.
Measure Section: Definition
Source of Change: Measure Lead
-
Updated denominator statement with removal of references to cryotherapy from the denominator statement to align with updated guideline.
Measure Section: Denominator
Source of Change: Expert Work Group Review
-
Updated parenthetical citations to align with American Psychological Association (APA) style.
Measure Section: Multiple Sections
Source of Change: Measure Lead
Logic
-
Replaced value set Cancer Staging (2.16.840.1.113883.3.526.3.1536) with direct reference code SNOMED CT code (258232002).
Measure Section: Denominator
Source of Change: Measure Lead
-
Updated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with CQL Style Guide.
Measure Section: Definitions and Functions
Source of Change: Standards Update
-
Updated Clinical Quality Language (CQL) expression to conform with the HL7 Standard: Clinical Quality Language Specification, Release 1 STU 3 (CQL 1.3).
Measure Section: Multiple Sections
Source of Change: Standards Update
Value Set
The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.
-
Value set Prostate Cancer Treatment (2.16.840.1.113883.3.526.3.398): Deleted 1 CPT code (55873). Added 2 SNOMED CT codes (427541000119103, 764675000) and deleted 8 SNOMED CT codes (169374002, 176319004, 265589001, 29860002, 420529003, 427357007, 433225000, 64978007).
Measure Section: Terminology
Source of Change: Annual Update
-
Value set Pain Related to Prostate Cancer (2.16.840.1.113883.3.526.3.451): Deleted 2 ICD-9-CM codes (V76.44, V84.03). Deleted 2 ICD-10-CM codes (Z12.5, Z15.03).
Measure Section: Terminology
Source of Change: Annual Update
-
Replaced value set Cancer Staging (2.16.840.1.113883.3.526.3.1536) with direct reference code SNOMED CT code (258232002).
Measure Section: Terminology
Source of Change: Measure Lead
-
Removed code system versions from direct reference codes. Please refer to Appendix A of the Electronic Clinical Quality Measure Logic and Implementation Guidance document for a list of code system versions used in the eCQM specifications for 2020 reporting/performance.
Measure Section: Terminology
Source of Change: Standards Update
-
Standardized purpose statement language in value sets across eCQMs. Value set purpose statements are visible in the Value Set Authority Center (VSAC) as well as the downloadable eCQM value set files.
Measure Section: Terminology
Source of Change: Measure Lead